Spain Brazil Russia France Germany China Korea Japan

Artificial Intelligence driven Marketing Communications

Oct 10, 2019 4:00 PM ET

Global DNA Vaccine Sales Revenue Is Nearly 3430 M USD In 2017




iCrowd Newswire - Oct 10, 2019

Global Info Research offers a latest published report on DNA Vaccines Market Analysis and Forecast 2019-2024 delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 158 pages which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability.

Click to view the full report TOC, figure and tables:

https://www.globalinforesearch.com/global-dna-vaccines-market_p106591.html

 

GIR logo

The DNA vaccine in this report refers to the vaccines manufactured using recombinant DNA technology. The advent of these vaccines has revolutionized the healthcare market. These vaccines are more effective, as well as have less side-effects associated with them as compared to traditional vaccines.

 

DNA vaccination is a technique for protecting against disease by injection with genetically engineered DNA so cells directly produce an antigen, producing a protective immunological response. DNA vaccines have potential advantages over conventional vaccines, including the ability to induce a wider range of immune response types.

 

In the last several years, Europe market of DNA Vaccine developed rapidly, with an average growth rate of 9.3%. In 2017, global sales revenue of DNA Vaccine is nearly 3430 M USD; the actual sale is about 74.8 million doses. Some of the major DNA vaccines include GlaxoSmithKline’s Engerix-B, Twinrix, and Fendrix; Merck’s Gardasil, and Recombivax HB; Protein Sciences Corporation’s Flublok, etc. Currently, the researchers are engaged in developing genetic vaccines for humans. Animal genetic vaccines are already present in the market. These vaccines are third generation vaccines and contain DNA that codes for specific proteins from a pathogen.

 

The classification of DNA Vaccine includes Recombinant Protein Vaccine and Gene-Based Vaccine. The revenue proportion of Recombinant Protein Vaccine in 2017 is about 99%.

 

DNA Vaccine is applied for human and animal. The most of DNA Vaccine is used for human, and the market share in 2017 is about 97.7%.

 

North America is the largest consumption place, with a revenue market share nearly 58% in 2017. Following North America, Europe is the second largest consumption place with the revenue market share of 28% in 2017. Asia-Pacific is also an important sales area, especially in China.

 

The top three players of the global market for DNA Vaccine is expected to witness an intense competitive scenario, the top four companies namely Merck, GSK, Sanofi held a share of around 92% in the global DNA Vaccine market in 2017. The study has publicized that though the numbers of DNA vaccines that target the human clinical segment are relatively fewer in number, however due to high sales of these vaccines, the DNA vaccine market is forecasted to show a phenomenal growth in the coming years.

For More Information On This Report, Please Visit @

https://www.globalinforesearch.com/global-dna-vaccines-market_p106591.html

 

Related Information:

North America Saddle Washers Market 2019 Forecast to 2024

United States Saddle Washers Market 2019 Forecast to 2024

Asia-Pacific Saddle Washers Market 2019 Forecast to 2024

Europe Saddle Washers Market 2019 Forecast to 2024

EMEA Saddle Washers Market 2019 Forecast to 2024

Global Saddle Washers Market 2019 Forecast to 2024

China Saddle Washers Market 2019 Forecast to 2024

 

 

Customization Service of the Report :
Global Info Research provides customization of reports as per your need. This report can be personalized to meet your requirements. Get in touch with our sales team, who will guarantee you to get a report that suits your necessities.

 

About Us:

GlobaI Info Research?GIR? is a report publisher, a customer, interest-based suppliers. Is in the best interests of our clients, they determine our every move. At the same time, we have great respect for the views of customers. With the improvement of the quality of our research, we develop custom interdisciplinary and comprehensive solution. For further development, we will do better and better. Global Info Research will with excellent professional knowledge and experience to carry out all aspects of our business. At the same time, we will thoroughly look for information, to give a more comprehensive development.



Contact Information:

Contact US
Global Info Research

E-mail: report@globalinforesearch.com

Tel:
+86-13660489451
00852-58197708(HK)

Add:FLAT/RM
A
9/F
SILVERCORP
INTERNATIONAL
TOWER
707-713
NATHAN
ROAD
MONGKOK
KL
HONG
KONG

Website: http://www.globalinforesearch.com






Keywords:    DNA Vaccine market share

Tags:    Extended Distribution, Research Newswire, English